Showing results (101-110 of 242) with videos related to
Sort By:
Pageof 25
Arthritis Research & Therapy|November 30, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trialsErnest H Choy, Marina Bendit, Dana McAleer, et al.Human Brain Mapping|July 10, 2020
Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's diseaseSebastian G Popescu, Alex Whittington, Roger N Gunn, et al.Synapse (New York, N.Y.)|May 4, 2011
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubisKhanum Ridler, Christophe Plisson, Eugenii A Rabiner, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 6, 2020
Test-retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brainAyla Mansur, Eugenii A Rabiner, Hideo Tsukada, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2010
In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNORagy R Girgis, Xiaoyan Xu, Nobumi Miyake, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 7, 2013
Kinetic analysis of drug-target interactions with PET for characterization of pharmacological hysteresisCristian Salinas, David Weinzimmer, Graham Searle, et al.IEEE Transactions on Medical Imaging|May 23, 2003
A linear wavelet filter for parametric imaging with dynamic PETFederico E Turkheimer, John A D Aston, Richard B Banati, et al.The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humansEugenii A Rabiner, Martin R Wilkins, Federico Turkheimer, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 17, 2021
Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challengeMattia Veronese, Gaia Rizzo, Martin Belzunce, et al.The American Journal of Psychiatry|February 20, 2016
Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107Tiago Reis Marques, Sridhar Natesan, Flavia Niccolini, et al.Pageof 25